WAVE Life Sciences LtdNASDAQ:WVE
- LAST PRICE5.4700
- TODAY'S CHANGE (%)0.1500 (2.8195%)
- Bid / Lots5.3200/ 1
- Ask / Lots5.5300/ 2
- Open / Previous Close5.2700 / 5.3200
- Day Range
- 52 Week Range
- Volume384,052
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | WVE |
|---|---|---|
| 09:32 ET | 3911 | 5.2682 |
| 09:34 ET | 5004 | 5.35 |
| 09:38 ET | 1114 | 5.31 |
| 09:39 ET | 1030 | 5.31 |
| 09:41 ET | 200 | 5.32 |
| 09:43 ET | 2900 | 5.31 |
| 09:45 ET | 400 | 5.315 |
| 09:50 ET | 400 | 5.32 |
| 09:52 ET | 1683 | 5.305 |
| 09:54 ET | 400 | 5.2843 |
| 09:56 ET | 1587 | 5.31 |
| 09:59 ET | 1065 | 5.29 |
| 10:01 ET | 100 | 5.3 |
| 10:03 ET | 1060 | 5.31 |
| 10:12 ET | 100 | 5.31 |
| 10:14 ET | 200 | 5.31 |
| 10:15 ET | 4117 | 5.305 |
| 10:17 ET | 300 | 5.3 |
| 10:19 ET | 1204 | 5.3 |
| 10:21 ET | 1121 | 5.31 |
| 10:24 ET | 200 | 5.31 |
| 10:28 ET | 200 | 5.31 |
| 10:30 ET | 400 | 5.32 |
| 10:32 ET | 334 | 5.33 |
| 10:33 ET | 1600 | 5.33 |
| 10:35 ET | 170 | 5.3201 |
| 10:37 ET | 300 | 5.32 |
| 10:39 ET | 600 | 5.3096 |
| 10:42 ET | 500 | 5.3005 |
| 10:44 ET | 600 | 5.31 |
| 10:48 ET | 227 | 5.315 |
| 10:50 ET | 1800 | 5.31 |
| 10:53 ET | 542 | 5.31 |
| 10:55 ET | 300 | 5.32 |
| 11:00 ET | 100 | 5.33 |
| 11:02 ET | 420 | 5.315 |
| 11:04 ET | 700 | 5.32 |
| 11:06 ET | 2000 | 5.3101 |
| 11:08 ET | 1091 | 5.33 |
| 11:11 ET | 400 | 5.33 |
| 11:15 ET | 142 | 5.33 |
| 11:18 ET | 100 | 5.32 |
| 11:22 ET | 100 | 5.33 |
| 11:24 ET | 897 | 5.3 |
| 11:26 ET | 437 | 5.31 |
| 11:27 ET | 100 | 5.3 |
| 11:29 ET | 2407 | 5.31 |
| 11:31 ET | 200 | 5.3 |
| 11:36 ET | 805 | 5.32 |
| 11:45 ET | 100 | 5.31 |
| 11:47 ET | 100 | 5.32 |
| 11:49 ET | 200 | 5.32 |
| 11:51 ET | 1200 | 5.3228 |
| 11:54 ET | 180 | 5.33 |
| 12:00 ET | 600 | 5.305 |
| 12:02 ET | 2270 | 5.31 |
| 12:03 ET | 118 | 5.31 |
| 12:07 ET | 1029 | 5.3 |
| 12:09 ET | 100 | 5.305 |
| 12:16 ET | 100 | 5.305 |
| 12:18 ET | 1800 | 5.3 |
| 12:20 ET | 100 | 5.3 |
| 12:25 ET | 982 | 5.3 |
| 12:27 ET | 505 | 5.3 |
| 12:30 ET | 100 | 5.3 |
| 12:32 ET | 2957 | 5.2801 |
| 12:34 ET | 1116 | 5.28 |
| 12:36 ET | 1770 | 5.29 |
| 12:38 ET | 776 | 5.3 |
| 12:39 ET | 600 | 5.3 |
| 12:41 ET | 1009 | 5.2883 |
| 12:43 ET | 1409 | 5.3 |
| 12:45 ET | 836 | 5.3 |
| 12:48 ET | 700 | 5.3 |
| 12:50 ET | 353 | 5.3 |
| 12:52 ET | 300 | 5.31 |
| 01:03 ET | 200 | 5.31 |
| 01:08 ET | 1273 | 5.3 |
| 01:10 ET | 200 | 5.31 |
| 01:19 ET | 352 | 5.305 |
| 01:21 ET | 100 | 5.3 |
| 01:24 ET | 100 | 5.31 |
| 01:26 ET | 228 | 5.3 |
| 01:30 ET | 100 | 5.31 |
| 01:33 ET | 2000 | 5.305 |
| 01:39 ET | 200 | 5.305 |
| 01:44 ET | 200 | 5.305 |
| 01:51 ET | 106 | 5.3009 |
| 01:53 ET | 1131 | 5.3 |
| 01:55 ET | 3320 | 5.32 |
| 01:57 ET | 100 | 5.33 |
| 02:00 ET | 200 | 5.33 |
| 02:06 ET | 811 | 5.33 |
| 02:08 ET | 200 | 5.335 |
| 02:11 ET | 100 | 5.335 |
| 02:13 ET | 4834 | 5.37 |
| 02:15 ET | 100 | 5.37 |
| 02:18 ET | 400 | 5.365 |
| 02:20 ET | 200 | 5.37 |
| 02:22 ET | 1492 | 5.361 |
| 02:24 ET | 200 | 5.365 |
| 02:26 ET | 1106 | 5.3608 |
| 02:29 ET | 5782 | 5.35 |
| 02:31 ET | 1599 | 5.36 |
| 02:33 ET | 1500 | 5.37 |
| 02:36 ET | 200 | 5.37 |
| 02:38 ET | 335 | 5.355 |
| 02:40 ET | 400 | 5.35 |
| 02:44 ET | 100 | 5.35 |
| 02:45 ET | 100 | 5.35 |
| 02:47 ET | 1931 | 5.355 |
| 02:54 ET | 200 | 5.355 |
| 02:56 ET | 200 | 5.36 |
| 02:58 ET | 100 | 5.355 |
| 03:02 ET | 3109 | 5.38 |
| 03:05 ET | 2922 | 5.4 |
| 03:07 ET | 200 | 5.41 |
| 03:09 ET | 1547 | 5.42 |
| 03:12 ET | 500 | 5.415 |
| 03:14 ET | 2400 | 5.42 |
| 03:18 ET | 400 | 5.415 |
| 03:21 ET | 2100 | 5.4102 |
| 03:23 ET | 100 | 5.415 |
| 03:30 ET | 3024 | 5.405 |
| 03:32 ET | 4887 | 5.4075 |
| 03:34 ET | 5207 | 5.415 |
| 03:36 ET | 12386 | 5.45 |
| 03:38 ET | 1500 | 5.47 |
| 03:39 ET | 2637 | 5.455 |
| 03:41 ET | 2931 | 5.455 |
| 03:43 ET | 3169 | 5.4612 |
| 03:45 ET | 1228 | 5.465 |
| 03:48 ET | 1542 | 5.4699 |
| 03:50 ET | 1400 | 5.45 |
| 03:52 ET | 5828 | 5.46 |
| 03:54 ET | 18154 | 5.5 |
| 03:56 ET | 16927 | 5.495 |
| 03:57 ET | 5932 | 5.495 |
| 03:59 ET | 89366 | 5.47 |
Jun 26, 2024
DJ Wave Life Sciences Price Target Maintained With a $15.00/Share by HC Wainwright & Co., from 8:45AM ET on Wednesday Jun 26, 2024 by Dow Jones
8:45AM ET on Wednesday Jun 26, 2024 by Dow Jones
Jun 25, 2024
DJ Wave Life Sciences Price Target Maintained With a $19.00/Share by Mizuho, from 12:49PM ET on Tuesday Jun 25, 2024 by Dow Jones
12:49PM ET on Tuesday Jun 25, 2024 by Dow JonesWave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington's Disease, from 7:30AM ET on Tuesday Jun 25, 2024 by Dow Jones
7:30AM ET on Tuesday Jun 25, 2024 by Dow Jones
Jun 20, 2024
DJ Obesity-Drug Developers Look at What's Next for a $100 Billion Market -- Barrons.com, from 2:51PM ET on Thursday Jun 20, 2024 by Dow Jones
2:51PM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 12, 2024
Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing, from 8:30AM ET on Wednesday Jun 12, 2024 by Dow Jones
8:30AM ET on Wednesday Jun 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
WAVE Life Sciences Ltd | 669.9M | -10.6x | --- |
SAGE Therapeutics Inc | 648.8M | -1.3x | --- |
Entrada Therapeutics Inc | 522.4M | 22.5x | --- |
Urogen Pharma Ltd | 653.8M | -4.7x | --- |
Travere Therapeutics Inc | 600.7M | -1.5x | --- |
Regenxbio Inc | 536.9M | -1.9x | --- |
Company Information
Wave Life Sciences Ltd. is a biotechnology company. The Company is focused on unlocking the potential of RNA medicines (oligonucleotides), or those targeting ribonucleic acid (RNA), to transform human health. Its RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing and RNA interference (RNAi), providing Company with capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. These programs include WVE-N531, WVE-006 and WVE-003. It is also building a pipeline of novel A-to-I RNA editing oligonucleotides (AIMers).
Contact Information
- Headquarters
- 7 Straits View #12-00, Marina One East Tower, Singapore 018936
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Christian Henry
- President, Chief Executive Officer, Director
- Paul Bolno
- Chief Financial Officer
- Kyle Moran
- Senior Vice President - Corporate Development, Head - Emerging Areas
- Christopher Francis
- Chief Technology Officer, Head - Platform Discovery Sciences
- Chandra Vargeese
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $669.9M |
|---|---|
Revenue (TTM) | $112.9M |
Shares Outstanding | 122.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.13 |
EPS | $-0.52 |
Book Value | $0.40 |
P/E Ratio | -10.6x |
Price/Sales (TTM) | 5.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -63.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
